Thomas Castellano
Director of Finance/CFO bei ABZENA PLC
Vermögen: 708 165 $ am 31.03.2024
Profil
Zurzeit ist Thomas P. Castellano Global Vice President-Operational Finance bei Catalent, Inc. Er ist außerdem Mitglied des Vorstands von Catalent France Beinheim SA. Thomas P. Castellano erwarb einen Bachelor-Abschluss und einen MBA an der Seton Hall University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CATALENT INC
0,01% | 04.12.2023 | 12 545 ( 0,01% ) | 708 165 $ | 31.03.2024 |
Aktive Positionen von Thomas Castellano
| Unternehmen | Position | Beginn |
|---|---|---|
| ABZENA PLC | Director of Finance/CFO | 05.06.2023 |
Catalent France Beinheim SA
 Catalent France Beinheim SA Pharmaceuticals: MajorHealth Technology Catalent France Beinheim SA is engaged in softgel development and manufacturing operations. It offers formulation development and manufacturing services for controlled substances, highly potent compounds, and hormones. The firm’s technologies include optiform® solution suite, optigel™ bio, and rp scherer softgel technology. The company was founded on May 3, 1965 and is headquartered in Beinheim, France. | Director/Board Member | - |
| Catalent Belgium Holding SA | Director/Board Member | 05.08.2021 |
Ehemalige bekannte Positionen von Thomas Castellano
| Unternehmen | Position | Ende |
|---|---|---|
| CATALENT, INC. | Director of Finance/CFO | 13.04.2023 |
Ausbildung von Thomas Castellano
| Seton Hall University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CATALENT, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Catalent Belgium Holding SA | |
Catalent France Beinheim SA
Catalent France Beinheim SA Pharmaceuticals: MajorHealth Technology Catalent France Beinheim SA is engaged in softgel development and manufacturing operations. It offers formulation development and manufacturing services for controlled substances, highly potent compounds, and hormones. The firm’s technologies include optiform® solution suite, optigel™ bio, and rp scherer softgel technology. The company was founded on May 3, 1965 and is headquartered in Beinheim, France. | Health Technology |
Abzena Ltd.
 Abzena Ltd. BiotechnologyHealth Technology Abzena Ltd. engages in the provision of proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It offers antibody discover and candidate screening, immunology and immunogenicity assessment, antibody and protein engineering, bio conjugation, custom synthesis of cytotoxic payloads, reagents, and other small molecules, manufacture of payload linkers, development of manufacturing cell lines, and manufacture of biopharmaceuticals. The company was founded by Sunil Shaunak in 2001 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
